Butylphthalide to reduce heart damage after a heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a drug called butylphthalide, given with a stent procedure, can reduce heart damage and improve recovery after a heart attack. You may join if you are having a heart attack and can get treated quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are having a heart attack (STEMI) and can get a stent procedure (PCI) within 12 hours of symptoms starting.
- You have not had a stent or heart bypass surgery before.
- You have not had a stroke or bleeding in the brain in the last 6 months.
- You do not have severe heart, kidney, liver, or bleeding problems.
- You are not pregnant, nursing, or planning to become pregnant in the next 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether butylphthalide, given after a procedure to remove a blood clot from the brain, can help reduce dangerous brain swelling. If you've had a severe stroke and recently had a clot-removal procedure, this drug might improve your recovery.
This trial tests if butylphthalide can improve brain function in people who have been resuscitated after a cardiac arrest. It may help reduce brain damage and improve recovery.
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
This study tests whether a medication called butylphthalide helps with long-term recovery after a mild stroke. It might improve thinking and memory over time.
This trial tests whether adding butylphthalide (a drug that improves blood flow) to the standard clot-busting medicine tenecteplase can help people with mild but disabling strokes recover better. If you have had a mild stroke within the last 4.5 hours and are 18–80, this study might be an option for you.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.